| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 614.40B | 610.52B | 555.84B | 492.69B | 441.80B | 408.59B |
| Gross Profit | 114.13B | 114.19B | 95.30B | 83.36B | 72.15B | 72.81B |
| EBITDA | 38.05B | 40.31B | 35.81B | 31.03B | 26.46B | 26.20B |
| Net Income | 21.29B | 22.10B | 19.00B | 15.58B | 7.90B | 4.26B |
Balance Sheet | ||||||
| Total Assets | 564.56B | 609.67B | 533.59B | 479.68B | 461.16B | 429.34B |
| Cash, Cash Equivalents and Short-Term Investments | 53.25B | 70.76B | 71.61B | 86.40B | 67.20B | 47.28B |
| Total Debt | 107.47B | 135.76B | 91.44B | 86.47B | 91.88B | 98.15B |
| Total Liabilities | 374.67B | 411.77B | 364.64B | 338.37B | 328.23B | 301.17B |
| Stockholders Equity | 181.24B | 189.37B | 162.66B | 139.62B | 131.30B | 126.33B |
Cash Flow | ||||||
| Free Cash Flow | -29.61B | -412.00M | -7.29B | 21.43B | 19.38B | 12.17B |
| Operating Cash Flow | -4.43B | 24.77B | 478.00M | 28.01B | 26.86B | 22.68B |
| Investing Cash Flow | -33.57B | -56.57B | -21.49B | -2.46B | 943.00M | -13.85B |
| Financing Cash Flow | 8.85B | 30.15B | -2.61B | -7.84B | -8.76B | -5.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥117.10B | 14.18 | ― | 3.20% | 2.46% | 533.70% | |
76 Outperform | ¥133.61B | 21.86 | 12.54% | 1.84% | 13.86% | 51.05% | |
72 Outperform | ¥905.67B | 16.97 | 6.61% | 1.58% | 5.02% | -27.41% | |
70 Outperform | ¥205.11B | -49.70 | ― | 2.41% | 2.47% | 1.47% | |
69 Neutral | ¥212.36B | 10.37 | 9.02% | 3.11% | 1.25% | -3.97% | |
68 Neutral | ¥729.40B | 23.01 | ― | 1.43% | 7.87% | 38.32% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |